NewLink Genetics Corp. is not just another company jumping on the bandwagon of the latest global health crisis – in this case, the Zika virus, a mosquito-borne illness rapidly spreading throughout Central and South America and certain US territories, with the first continental US transmission of the disease reported on Feb. 2, which apparently involved sexual contact.
Indeed, the Ames, Iowa-based biotech, which recently gained worldwide recognition for its experimental Ebola vaccine – which so far has...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
